Repeated Transarterial Chemoembolization with Degradable Starch Microspheres (DSMs-TACE) of Unresectable Hepatocellular Carcinoma: A Prospective Pilot Study-Reference-Cited by-同舟云学术

Repeated Transarterial Chemoembolization with Degradable Starch Microspheres (DSMs-TACE) of Unresectable Hepatocellular Carcinoma: A Prospective Pilot Study

Published:2018-07-09 Issue:4 Volume:14 Page:637-645
ISSN:1573-4056
Container-title:Current Medical Imaging Reviews
language:en
Short-container-title:CMIR

Author:

Orlacchio Antonio¹,Chegai Fabrizio¹,Francioso Simona²,Merolla Stefano¹,Monti Serena³,Angelico Mario²,Tisone Giuseppe⁴,Mannelli Lorenzo⁵

Affiliation:

1. Department of Diagnostic and Molecular Imaging, Radiation Therapy and Interventional Radiology University Hospital Tor Vergata, Viale Oxford 81, 00133 Rome, Italy

2. Liver Unit, University Hospital Tor Vergata, Rome, Italy

3. IRCCS SDN, Naples, Italy

4. Organ Transplantation Unit, University Hospital Tor Vergata, Rome, Italy

5. Department of Radiology, Memorial Sloan-Kettering Cancer Center, New York, NY, United States

Publisher

Bentham Science Publishers Ltd.

Subject

Radiology, Nuclear Medicine and imaging

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The Use of Microspheres for Cancer Embolization Therapy: Recent Advancements and Prospective;ACS Biomaterials Science & Engineering;2024-01-26

2. Transarterial Chemoembolization with Degradable Starch Microspheres (DSM-TACE);Transarterial Chemoembolization (TACE);2023

3. Clinical effects and safety of different transarterial chemoembolization methods for bridging and palliative treatments in hepatocellular carcinoma;Journal of Cancer Research and Clinical Oncology;2022-01-25

4. A real-world study of Chinese hepatocellular carcinoma patients treated with TACE;EUR REV MED PHARMACO;2022

5. Safety and Efficacy of Degradable Starch Microspheres Transcatheter Arterial Chemoembolization as a Bridging Therapy in Patients with Early Stage Hepatocellular Carcinoma and Child-Pugh Stage B Eligible for Liver Transplant;Frontiers in Pharmacology;2021-04-09